JFNNX: Janus Henderson Global Life Sciences Fund - MutualFunds.com
Continue to site >
Trending ETFs

Welcome to MutualFunds.com

Please help us personalize your experience and select the one that best describes you.

Your personalized experience is almost ready.

Join other Individual Investors receiving FREE personalized market updates and research. Join other Institutional Investors receiving FREE personalized market updates and research. Join other Financial Advisors receiving FREE personalized market updates and research.
Not interested

Thank you!

Check your email and confirm your subscription to complete your personalized experience.

Thank you for your submission

We hope you enjoy your experience

You have successfully subscribed to Advisor Access. Thank you!
Help us personalize your experience.
Which type of investor describes you best?
Help us personalize your experience.
What is your AUM?
Knowing your investable assets will help us build and prioritize features that will suit your investment needs.

Congratulations on personalizing your experience.

Email is verified. Thank you!

Janus Henderson Global Life Sciences N

JFNNX - Snapshot

Vitals

  • YTD Return -1.0%
  • 3 Yr Annualized Return 16.8%
  • 5 Yr Annualized Return 15.5%
  • Net Assets $4.77 B
  • Holdings in Top 10 28.4%

52 WEEK LOW AND HIGH

$70.39
$57.77
$75.72

Expenses

OPERATING RELATED FEES

  • Expense Ratio 0.67%

SALES FEES

  • Front Load N/A
  • Deferred Load N/A

BROKERAGE FEES

  • Turnover 43.00%

TRADING FEES

  • Max Redemption Fee N/A

Min Investment

  • Standard (Taxable) $1,000,000
  • IRA N/A

Fund Classification

Compare JFNNX to Popular Health Care Sector Equity Funds and ETFs

Overview

Income Profile

Income Risk

Returns Profile

Allocations

Expenses

About

Vanguard Health Care Fund

Fund

$218.37

+0.56%

$47.58 B

0.99%

$2.16

1.23%

0.32%

Health Care Select Sector SPDR® Fund

XLV | ETF

$121.48

+0.75%

$24.60 B

1.41%

$1.70

7.09%

0.13%

T. Rowe Price Health Sciences Fund

Fund

$101.80

+0.13%

$17.47 B

-

$0.00

2.98%

0.76%

Vanguard Health Care Index Fund

Fund

$118.91

+0.56%

$16.24 B

1.23%

$1.45

6.26%

0.10%

Vanguard Health Care Index Fund

VHT | ETF

$237.79

+0.45%

$16.24 B

1.23%

$2.90

6.28%

0.10%

JFNNX - Profile

Distributions

  • YTD Total Return -1.0%
  • 3 Yr Annualized Total Return 16.8%
  • 5 Yr Annualized Total Return 15.5%
  • Capital Gain Distribution Frequency Annually
  • Net Income Ratio 1.08%
DIVIDENDS
  • Dividend Yield 0.0%
  • Dividend Distribution Frequency Annually

Fund Details

  • Legal Name
    Janus Henderson Global Life Sciences Fund
  • Fund Family Name
    Janus Henderson
  • Inception Date
    Jan 26, 2018
  • Shares Outstanding
    N/A
  • Share Class
    N
  • Currency
    USD
  • Domiciled Country
    United States
  • Manager
    Andrew Acker

Fund Description

The fund pursues its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that the portfolio managers believe have a life science orientation. In the fund's pursuit of companies with a life science orientation, the fund has a fundamental policy to normally invest at least 25% of its total assets in securities of companies that are categorized in the "life sciences" sector.

JFNNX - Performance

Return Ranking - Trailing

Period JFNNX Return Category Return Low Category Return High Rank in Category (%)
YTD -1.0% -46.5% 19.7% 80.92%
1 Yr 41.7% 21.1% 184.4% 38.79%
3 Yr 16.8%* 1.3% 54.0% 21.92%
5 Yr 15.5%* 5.2% 40.3% 30.00%
10 Yr 17.6%* 9.4% 20.2% 16.94%

* Annualized

Return Ranking - Calendar

Period JFNNX Return Category Return Low Category Return High Rank in Category (%)
2020 16.4% -13.6% 178.2% 37.65%
2019 21.5% 3.8% 63.8% 43.84%
2018 N/A -49.7% 21.5% N/A
2017 N/A -59.8% 54.4% N/A
2016 N/A -36.6% 11.6% N/A

Total Return Ranking - Trailing

Period JFNNX Return Category Return Low Category Return High Rank in Category (%)
YTD -1.0% -46.5% 19.7% 80.92%
1 Yr 41.7% 14.7% 184.4% 35.76%
3 Yr 16.8%* 1.3% 54.0% 20.55%
5 Yr 15.5%* 5.0% 40.3% 27.14%
10 Yr 17.6%* 9.3% 20.2% 16.94%

* Annualized

Total Return Ranking - Calendar

Period JFNNX Return Category Return Low Category Return High Rank in Category (%)
2020 16.4% -13.6% 178.2% 37.65%
2019 21.5% 3.8% 63.8% 43.84%
2018 N/A -25.3% 22.2% N/A
2017 N/A -10.8% 54.4% N/A
2016 N/A -36.6% 11.6% N/A

NAV & Total Return History

JFNNX - Holdings

Concentration Analysis

JFNNX Category Low Category High JFNNX % Rank
Net Assets 4.77 B 2.48 M 47.6 B 17.71%
Number of Holdings 120 26 450 21.71%
Net Assets in Top 10 1.42 B 239 K 19.6 B 20.00%
Weighting of Top 10 28.40% 7.6% 77.3% 82.86%

Top 10 Holdings

  1. UnitedHealth Group Inc 3.54%
  2. AstraZeneca PLC 3.36%
  3. AstraZeneca PLC 3.36%
  4. AstraZeneca PLC 3.36%
  5. AstraZeneca PLC 3.36%
  6. AstraZeneca PLC 3.36%
  7. AstraZeneca PLC 3.36%
  8. AstraZeneca PLC 3.36%
  9. AstraZeneca PLC 3.36%
  10. AstraZeneca PLC 3.36%

Asset Allocation

Weighting Return Low Return High JFNNX % Rank
Stocks 		92.05% 82.92% 105.23% 93.71%
Other 		7.17% -26.63% 10.48% 5.14%
Cash 		0.78% -0.23% 10.92% 45.71%
Preferred Stocks 		0.00% 0.00% 5.58% 65.71%
Convertible Bonds 		0.00% 0.00% 0.02% 58.29%
Bonds 		0.00% 0.00% 18.37% 61.14%

Stock Sector Breakdown

Weighting Return Low Return High JFNNX % Rank
Healthcare 		99.90% 22.48% 100.00% 32.00%
Financial Services 		0.10% 0.00% 10.87% 39.43%
Utilities 		0.00% 0.00% 1.24% 58.29%
Technology 		0.00% 0.00% 27.24% 66.86%
Real Estate 		0.00% 0.00% 6.18% 62.86%
Industrials 		0.00% 0.00% 4.84% 64.00%
Energy 		0.00% 0.00% 0.03% 58.86%
Communication Services 		0.00% 0.00% 13.83% 61.14%
Consumer Defense 		0.00% 0.00% 30.57% 59.43%
Consumer Cyclical 		0.00% 0.00% 14.05% 62.86%
Basic Materials 		0.00% 0.00% 3.70% 73.71%

Stock Geographic Breakdown

Weighting Return Low Return High JFNNX % Rank
US 		73.79% 58.67% 101.51% 78.86%
Non US 		18.26% 0.00% 40.32% 25.71%

JFNNX - Expenses

Operational Fees

JFNNX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Expense Ratio 0.67% 0.08% 25.14% 77.06%
Management Fee 0.64% 0.00% 1.25% 52.00%
12b-1 Fee N/A 0.00% 1.00% N/A
Administrative Fee 0.12% 0.03% 0.25% 57.14%

Sales Fees

JFNNX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Front Load N/A 3.50% 5.75% N/A
Deferred Load N/A 1.00% 5.00% N/A

Trading Fees

JFNNX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Max Redemption Fee N/A 1.00% 2.00% N/A

Related Fees

Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.

JFNNX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Turnover 43.00% 0.70% 252.00% 53.33%

JFNNX - Distributions

Dividend Yield Analysis

JFNNX Category Low Category High JFNNX % Rank
Dividend Yield 0.00% 0.00% 0.97% 65.14%

Dividend Distribution Analysis

JFNNX Category Low Category High Category Mod
Dividend Distribution Frequency Annually Annually Annually Annually

Net Income Ratio Analysis

JFNNX Category Low Category High JFNNX % Rank
Net Income Ratio 1.08% -2.53% 1.74% 7.60%

Capital Gain Distribution Analysis

JFNNX Category Low Category High Capital Mode
Capital Gain Distribution Frequency Annually Annually Annually Annually

Dividend Payout History

View More +

JFNNX - Fund Manager Analysis

Managers

Andrew Acker

Start Date

Tenure

Tenure Rank

May 01, 2007

13.93

13.9%

Andy Acker is a Portfolio Manager at Janus Henderson Investors responsible for managing the Global Life Sciences and Biotechnology strategies since 2007 and 2018, respectively. He also leads the firm’s Health Care Sector Research Team. Andy was assistant portfolio manager on the Global Life Sciences strategy from 2003 to 2007. He joined Janus in 1999 as a research analyst focused on companies in the biotechnology and pharmaceutical industries. Prior to this, he worked as a strategy consultant for the Boston Consulting Group and as a health care analyst for Morgan Stanley Venture Partners. Andy received his bachelor of science degree in biochemical sciences from Harvard University, graduating magna cum laude and Phi Beta Kappa. He also earned an MBA with honours from Harvard Business School. Andy holds the Chartered Financial Analyst designation and has 23 years of financial industry experience.

Tenure Analysis

Category Low Category High Category Average Category Mode
0.04 23.56 7.25 20.93

Advertisement

×

Wait! Do you know all the important aspects of mutual funds?

×

Free Advisor Access newsletter emailed to you.

Receive free and exclusive email updates for financial advisors about best performers, news, CE accredited webcasts and more.

Sign up for Advisor Access

Receive email updates about best performers, news, CE accredited webcasts and more.

Disclaimer: By registering, you agree to share your data with MutualFunds.com and opt-in to receiving occasional communications about projects and events. The contents of this form are subject to the MutualFunds.com Privacy Policy. You can unsubscribe at any time.